What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
Mark L. Rosenblum spends much of his time researching Pathology, Surgery, Magnetic resonance imaging, Glioma and Radiation therapy.
His Pathology research integrates issues from In vitro, Rat brain and Central nervous system.
EMG abnormality, Denervation and Radiculopathies is closely connected to Anesthesia in his research, which is encompassed under the umbrella topic of Surgery.
The Magnetic resonance imaging study which covers Biopsy that intersects with Necrosis, Complication, Headaches and Dura mater.
To a larger extent, he studies Cancer research with the aim of understanding Glioma.
The various areas that he examines in his Radiation therapy study include Tumor progression, Acquired immunodeficiency syndrome and Incidence.
His most cited work include:
- Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience at UCSF and review of the literature (950 citations)
- Clonal expansion of p53 mutant cells is associated with brain tumour progression (623 citations)
- Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. (517 citations)
What are the main themes of his work throughout his whole career to date?
Mark L. Rosenblum focuses on Pathology, Surgery, Glioma, Brain tumor and Cancer research.
His work deals with themes such as Laminin and Extracellular matrix, which intersect with Pathology.
His Surgery study frequently links to adjacent areas such as Radiology.
As a member of one scientific family, Mark L. Rosenblum mostly works in the field of Glioma, focusing on Cell culture and, on occasion, Glial fibrillary acidic protein, Fibronectin, Cell and Cytotoxic T cell.
His Brain tumor study integrates concerns from other disciplines, such as Clonogenic assay and Chemotherapy.
Mark L. Rosenblum works mostly in the field of Cancer research, limiting it down to topics relating to In vitro and, in certain cases, Nitrosourea, Immunology, Molecular biology and Stem cell.
He most often published in these fields:
- Pathology (26.94%)
- Surgery (18.78%)
- Glioma (18.78%)
What were the highlights of his more recent work (between 2004-2020)?
- Glioma (18.78%)
- Pathology (26.94%)
- Cancer research (14.69%)
In recent papers he was focusing on the following fields of study:
Mark L. Rosenblum mainly focuses on Glioma, Pathology, Cancer research, Nuclear medicine and Neurology.
His Glioma research is multidisciplinary, incorporating perspectives in Pseudoaneurysm, Chemotherapy, Cranial nerves, Primary tumor and In vivo.
His work carried out in the field of Chemotherapy brings together such families of science as Brain tumor, In vitro, Stem cell and Oncology.
His Pathology study combines topics in areas such as Case description, Glioblastoma and Subarachnoid hemorrhage.
His Cancer research research is multidisciplinary, incorporating elements of Liquid biopsy, Regulation of gene expression, Epigenetics and DNA methylation.
His studies deal with areas such as Survival rate, Radiosurgery, Perfusion and Medical imaging as well as Nuclear medicine.
Between 2004 and 2020, his most popular works were:
- Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience at UCSF and review of the literature (950 citations)
- Partial volume tolerance of the spinal cord and complications of single-dose radiosurgery† (214 citations)
- Genomic Changes and Gene Expression Profiles Reveal That Established Glioma Cell Lines Are Poorly Representative of Primary Human Gliomas (188 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
His scientific interests lie mostly in Glioma, Radiosurgery, Radiation therapy, Nuclear medicine and Magnetic resonance imaging.
His research integrates issues of In vitro, Primary tumor, Chemotherapy and Cell growth in his study of Glioma.
His Radiosurgery study incorporates themes from Rachis and Oncology.
His study explores the link between Radiation therapy and topics such as Physical examination that cross with problems in Radiography, Retrospective cohort study, Salvage therapy, Tumor progression and Neurology.
His Nuclear medicine research incorporates themes from Survival rate, Perfusion and Medical imaging.
His Pathology research is multidisciplinary, relying on both Dermatology and Gene.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
